RARE-34. DIAGNOSIS AND MOLECULAR CHARACTERIZATION OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM UVEAL MELANOMA (UM)
CONCLUSIONS & FUTURE DIRECTIONS:It is possible to make a diagnosis and molecular characterization of LMDz when conventional methods fail using CSF-CTCs. A focused mutational analysis for potential therapeutically relevant targets can be used to guide treatment. The relationship of this selected CSF-CTC marker to the population of CSF-CTCs and therapeutic decisions are being clarified.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Fedorenko, I., Evernden, B., Kenchappa, R., Sahebjam, S., Ryzhova, E., Puskas, J., Magliocco, A., Etame, A. B., Tran, N. D., Harbour, W., Smalley, K., Forsyth, P. Tags: RARE TUMORS Source Type: research
More News: Brain | Brain Cancers | Cancer & Oncology | Cytology | Eye Cancers | Genetics | Laboratory Medicine | Liver | Mammography | Melanoma | Men | Neurology | Skin Cancer | Urology & Nephrology | Uveal Melanoma